Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 165(3): 1352-6, 2000 Aug 01.
Article in English | MEDLINE | ID: mdl-10903737

ABSTRACT

CTLA-4 (CD152) engagement results in down-regulation of T cell activation. Two mechanisms have been postulated to explain CTLA-4 inhibition of T cell activation: negative signaling and competitive antagonism of CD28:B7-mediated costimulation. We assessed the contributions of these two mechanisms using a panel of T cell lines expressing human CTLA-4 with mutations in the cytoplasmic region. Under conditions of B7-independent costimulation, inhibition of IL-2 production following CTLA-4 engagement required the CTLA-4 cytoplasmic region. In contrast, under B7-dependent costimulation, inhibition of IL-2 production by CTLA-4 engagement was directly proportional to CTLA-4 cell surface levels and did not require its cytoplasmic region. Thus, CTLA-4 down-regulates T cell activation by two different mechanisms-delivery of a negative signal or B7 sequestration-that are operational depending on the levels of CTLA-4 surface expression. These two mechanisms may have distinct functional outcomes: rapid inhibition of T cell activation or induction of T cell anergy.


Subject(s)
Antigens, Differentiation/biosynthesis , Antigens, Differentiation/immunology , Immunoconjugates , Immunosuppressive Agents/pharmacology , Lymphocyte Activation/immunology , T-Lymphocytes/immunology , Abatacept , Amino Acid Sequence , Antibodies, Monoclonal/pharmacology , Antigens, CD/immunology , Antigens, Differentiation/genetics , Antigens, Differentiation/physiology , B7-1 Antigen/physiology , B7-2 Antigen , CD28 Antigens/immunology , CD3 Complex/immunology , CTLA-4 Antigen , Cell Membrane/immunology , Cell Membrane/metabolism , Cytoplasm/immunology , Down-Regulation/immunology , Doxycycline/pharmacology , Humans , Immunoglobulin Fc Fragments/genetics , Immunoglobulin Fc Fragments/physiology , Interleukin-2/biosynthesis , Jurkat Cells , Lymphocyte Activation/drug effects , Membrane Glycoproteins/immunology , Microspheres , Molecular Sequence Data , Peptide Fragments/immunology , Recombinant Fusion Proteins/immunology , Recombinant Fusion Proteins/pharmacology , Signal Transduction/immunology , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...